147 related articles for article (PubMed ID: 18421705)
1. Sunlight ultraviolet irradiation and BRAF V600 mutagenesis in human melanoma.
Besaratinia A; Pfeifer GP
Hum Mutat; 2008 Aug; 29(8):983-91. PubMed ID: 18421705
[TBL] [Abstract][Full Text] [Related]
2. Could BRAF mutations in melanocytic lesions arise from DNA damage induced by ultraviolet radiation?
Thomas NE; Berwick M; Cordeiro-Stone M
J Invest Dermatol; 2006 Aug; 126(8):1693-6. PubMed ID: 16845408
[TBL] [Abstract][Full Text] [Related]
3. BRAF V600 mutations and pathological features in Japanese melanoma patients.
Yamazaki N; Tanaka R; Tsutsumida A; Namikawa K; Eguchi H; Omata W; Oashi K; Ogawa T; Hayashi A; Nakamura N; Tsuta K
Melanoma Res; 2015 Feb; 25(1):9-14. PubMed ID: 25051202
[TBL] [Abstract][Full Text] [Related]
4. BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site.
Bauer J; Büttner P; Murali R; Okamoto I; Kolaitis NA; Landi MT; Scolyer RA; Bastian BC
Pigment Cell Melanoma Res; 2011 Apr; 24(2):345-51. PubMed ID: 21324100
[TBL] [Abstract][Full Text] [Related]
5. Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma.
Thomas NE; Edmiston SN; Alexander A; Millikan RC; Groben PA; Hao H; Tolbert D; Berwick M; Busam K; Begg CB; Mattingly D; Ollila DW; Tse CK; Hummer A; Lee-Taylor J; Conway K
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):991-7. PubMed ID: 17507627
[TBL] [Abstract][Full Text] [Related]
6. Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patients.
Schlaak M; Bajah A; Podewski T; Kreuzberg N; von Bartenwerffer W; Wardelmann E; Merkelbach-Bruse S; Büttner R; Mauch C; Kurschat P
Br J Dermatol; 2013 Apr; 168(4):708-16. PubMed ID: 23528057
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features and clinical outcomes associated with TP53 and BRAF
Kim DW; Haydu LE; Joon AY; Bassett RL; Siroy AE; Tetzlaff MT; Routbort MJ; Amaria RN; Wargo JA; McQuade JL; Kemnade J; Hwu P; Woodman SE; Roszik J; Kim KB; Gershenwald JE; Lazar AJ; Davies MA
Cancer; 2017 Apr; 123(8):1372-1381. PubMed ID: 27911979
[TBL] [Abstract][Full Text] [Related]
8. BRAF V600 mutation profiling in primary skin nodular melanoma in Indonesia: an analysis using high resolution pyrosequencing.
Rinonce HT; Aji RPM; Hayati N; Pudjohartono MF; Kameswari B; Anwar SL; Irianiwati
BMC Res Notes; 2020 Mar; 13(1):164. PubMed ID: 32188503
[TBL] [Abstract][Full Text] [Related]
9. Hybrid Capture-Based Genomic Profiling Identifies BRAF V600 and Non-V600 Alterations in Melanoma Samples Negative by Prior Testing.
Boussemart L; Nelson A; Wong M; Ross JS; Sosman J; Mehnert J; Daniels G; Kendra K; Ali SM; Miller VA; Schrock AB
Oncologist; 2019 May; 24(5):657-663. PubMed ID: 30683711
[TBL] [Abstract][Full Text] [Related]
10. Distinct sets of genetic alterations in melanoma.
Curtin JA; Fridlyand J; Kageshita T; Patel HN; Busam KJ; Kutzner H; Cho KH; Aiba S; Bröcker EB; LeBoit PE; Pinkel D; Bastian BC
N Engl J Med; 2005 Nov; 353(20):2135-47. PubMed ID: 16291983
[TBL] [Abstract][Full Text] [Related]
11. Impact of Sun Exposure and Tanning Patterns on Next-Generation Sequencing Mutations in Melanoma.
Loo K; Soliman I; Renzetti M; Li T; Wu H; Reddy S; Olszanski AJ; Farma JM
J Surg Res; 2020 Oct; 254():147-153. PubMed ID: 32445930
[TBL] [Abstract][Full Text] [Related]
12. Metaanalysis of BRAF mutations and clinicopathologic characteristics in primary melanoma.
Kim SY; Kim SN; Hahn HJ; Lee YW; Choe YB; Ahn KJ
J Am Acad Dermatol; 2015 Jun; 72(6):1036-46.e2. PubMed ID: 25819940
[TBL] [Abstract][Full Text] [Related]
13. Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanoma.
Pisareva E; Gutkina N; Kovalenko S; Kuehnapfel S; Hartmann A; Heinzerling L; Schneider-Stock R; Lyubchenko L; Shamanin VA
Melanoma Res; 2014 Aug; 24(4):322-31. PubMed ID: 24922189
[TBL] [Abstract][Full Text] [Related]
14. BRAF analysis on a spectrum of melanocytic neoplasms: an epidemiological study across differing UV regions.
Saroufim M; Habib R; Karram S; Youssef Massad C; Taraif S; Loya A; Houreih MA; Sheikh SS; Amr SS; Satti M; Oberkanins C; Khalifeh I
Am J Dermatopathol; 2014 Jan; 36(1):68-73. PubMed ID: 23782679
[TBL] [Abstract][Full Text] [Related]
15. Comparison between two widely used laboratory methods in BRAF V600 mutation detection in a large cohort of clinical samples of cutaneous melanoma metastases to the lymph nodes.
Jurkowska M; Gos A; Ptaszyński K; Michej W; Tysarowski A; Zub R; Siedlecki JA; Rutkowski P
Int J Clin Exp Pathol; 2015; 8(7):8487-93. PubMed ID: 26339422
[TBL] [Abstract][Full Text] [Related]
16. BRAF-V600 mutational status affects recurrence patterns of melanoma brain metastasis.
Maxwell R; Garzon-Muvdi T; Lipson EJ; Sharfman WH; Bettegowda C; Redmond KJ; Kleinberg LR; Ye X; Lim M
Int J Cancer; 2017 Jun; 140(12):2716-2727. PubMed ID: 27342756
[TBL] [Abstract][Full Text] [Related]
17. The association between MC1R genotype and BRAF mutation status in cutaneous melanoma: findings from an Australian population.
Hacker E; Hayward NK; Dumenil T; James MR; Whiteman DC
J Invest Dermatol; 2010 Jan; 130(1):241-8. PubMed ID: 19571821
[TBL] [Abstract][Full Text] [Related]
18. BRAF-V600 Mutation Heterogeneity in Primary and Metastatic Melanoma: A Study With Pyrosequencing and Immunohistochemistry.
Yaman B; Kandiloğlu G; Akalin T
Am J Dermatopathol; 2016 Feb; 38(2):113-20. PubMed ID: 26630683
[TBL] [Abstract][Full Text] [Related]
19. [Response of BRAF(L597Q)-mutant melanoma to trametinib : Targeted melanoma therapy beyond BRAF(V600) mutations].
Haase O; Angün O; Grätz V; Lüttmann N; Neumann A; Zillikens D; Terheyden P
Hautarzt; 2016 Aug; 67(8):648-52. PubMed ID: 27146499
[TBL] [Abstract][Full Text] [Related]
20. Skin cancer and solar UV radiation.
de Gruijl FR
Eur J Cancer; 1999 Dec; 35(14):2003-9. PubMed ID: 10711242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
